CNBX stock CNBX Pharmaceuticals Inc. (PNK) earnings 12 Jan 2026: key catalysts

CNBX stock jumps into the spotlight as CNBX Pharmaceuticals Inc. (PNK) prepares to report results on 12 Jan 2026 during U.S. market hours. We look at the tiny-market-cap biotech’s financials, trading activity and clinical pipeline ahead of the report. CNBX Pharmaceuticals Inc. trades on the PNK exchange in the United States and carries a market cap of 46,256.00 USD on 114,115,197.00 shares traded today. Key metrics include EPS -0.01 and PE -0.05, which highlight the firm’s early-stage, pre-revenue profile and high risk-reward for short-term traders and long-term investors.